日期 | 时间 | 会场 | Session | 角色 | 讲题 |
---|---|---|---|---|---|
2020-09-26 | 16:10-16:20 | 移植/404 |
移植 25(发言8分钟+讨论2分钟) |
讲者 | Comparable outcomes but better GVHD-free and relapse-free survival of preemptive low-dose recombinant interleukin-2 versus donor lymphocyte infusion for late-onset minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hemato |